Pharmaceutical Business definition

Pharmaceutical Business shall have the meaning set forth in the preamble of this Agreement.

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Pharmaceutical Business means research, development, manufacturing, distribution, sales and marketing of branded and generic pharmaceutical products, including active pharmaceutical ingredients, as conducted by the Company Parties on the date hereof and the activities relating to biogenerics, antiretrovirals and finished dosage form products, as contemplated to be conducted by the Company Parties as of the date hereof.

Pharmaceutical Business means the discovery, development, manufacture, marketing or distribution of pharmaceutical or vaccine products.

Examples of Pharmaceutical Business in a sentence

To the extent such provision is not permitted by Applicable Law, Licensor shall cooperate with Licensee to permit Licensee, to the fullest extent permitted by Applicable Law, to utilize the TO Strains in connection with the Pharmaceutical Products and Licensee’s Pharmaceutical Business.
Licensor shall not use or grant the right to use the Licensor IP to another third-party in connection with the Pharmaceutical Business in the Territory other than to an Affiliate of Licensee.
For the Purpose of Section 2 of this Agreement, the term Cannabis Business shall exclude any Pharmaceutical Business.
Licensee shall have the right to grant sublicenses of any of its rights under this License in connection with the Pharmaceutical Business solely within the Territory.
Both Parties agree reasonably to cooperate with and assist each other in connection with the License granted under this Agreement and the development and success of Licensee’s Pharmaceutical Business within the Territory.
Should Licensee or any person on its behalf sell, convey, transfer to or otherwise dispose of any real property on which any of the TO Strains or New Strains shall have been cultivated in connection with the Pharmaceutical Products or the Pharmaceutical Business, Licensee shall inform Licensor in writing, in advance of such sale, conveyance, transfer or disposition of the land and provide reasonable details regarding the intended transferee thereof.
The Parties recognize that, notwithstanding anything implicitly or explicitly to the contrary in this Agreement, the License granted hereunder does not grant any rights with respect to any use of Licensor IP or Licensee IP other than with respect to Licensee's Pharmaceutical Business within the Territory.
Licensee shall have the right to use all New IP owned by it solely in connection with the Pharmaceutical Business, and/or license to third parties the right to use such New IP, solely in connection to the Pharmaceutical Business, in each case solely within the Territory.
The Parties agree that upon written request from either Party that certain information relating to the Cyclerion Pharmaceutical Business, the New Ironwood Pharmaceutical Business or the transactions contemplated hereby be retained in connection with an Action, the other Party shall use reasonable efforts to preserve and not to destroy or dispose of such information without the consent of the requesting Party.
The Parties agree to reasonably cooperate with and assist each other in connection with the sublicense granted under this Agreement and the development and success of commercializing the Sublicensed IP in connection with the Limited Pharmaceutical Business, including in executing documents and joining in any litigation as needed to ensure proper standing for such litigation.

More Definitions of Pharmaceutical Business

Pharmaceutical Business shall have the meaning set forth in the preamble of this Agreement. 51. “Pharmaceutical Product” shall mean any product, compound, medicine or therapeutic which is subject to regulation as a drug, medicine or controlled substance by the FDA. 52. “Receiving Party” shall have the meaning set forth in Section 9 of this Agreement. 53. “Representative” shall mean any director, officer, employee, member, manager, agent, contractor or advisor who shall have access to any Confidential Information. 54. “Residual Information” means any Confidential Information, which may be retained, following the termination of this Agreement, in intangible form in the minds of the Representatives. 55. “Services” shall mean the Training Services, the Design and Operations Services and the Clinical Trials Services. 56. “Shortfall” shall have the meaning set forth in Section 13.3 of this Agreement. 57. “Territory” shall have the meaning set forth in Section 2.1 of this Agreement. 58. “Third-Party Claim” shall have the meaning set forth in Section 13.4 of this Agreement. 59. “Third-Party IP” shall have the meaning set forth in Section 2.9 of this Agreement. 60. “TO LLC” shall have the meaning set forth in Section 2.2 of this Agreement. 61. “TO Strains” shall have the meaning set forth in Section 2.6 of this Agreement. 62. “Training Services” shall have the meaning set forth in Section 7.1(b) of this Agreement. 63. “United States” shall mean the United States of America and its territories and possessions. 64. “USA Payment” shall have the meaning set forth in Section 3 of this Agreement. 65. “US Medical Cannabis License Agreement” shall have the meaning set forth in Section2.2 of this Agreement. 66. “Valuator” shall have the meaning set forth in Section 16.6 of this Agreement.

Pharmaceutical Business means the portion of AMBI's business which relates to the sale of animal or human Nisin or Nisin-related products or technology, including, without limitation, its "Wipe-Out" product line.